Hong Kong-based drug discovery and development company Insilico has secured fresh capital at a time that its CEO described as a "biotech winter." The firm has raised $35 million on the heels of its last tranche in June, bringing its total Series D investment to $95 million. The new round was "oversubscribed", the firm's founder and CEO Alex Zhavoronkov told TechCrunch, declining to disclose the company's valuation. Prosperity7, the venture capital arm of Saudi Arabia's state oil company Aramco, led the new capital infusion. The fund has been actively scouring for opportunities in and around China that can scale globally and particularly in the Middle East.

Jaka Robotics, a Chinese startup that makes collaborative robots, has just pulled in a hefty Series D funding round of over $150 million from a lineup of heavyweight investors to help it expand globally. The round is led by Singapore's sovereign wealth fund Temasek, TrueLight Capital, Softbank Vision Fund II, and Prosperity7 Ventures, a growth fund under Aramco Ventures, which is an investment subsidiary of Saudi Arabia's state oil firm Aramco. Collaborative robots, known as "cobots", are meant to work alongside humans rather than in isolation. Based out of Shanghai and Beijing, Jaka's robotic arms can augment humans in a range of tasks, from assembling electronic parts, pouring from a coffee machine to packaging smartphones. Jaka plans to spend its fresh funding on R&D and global expansion, which makes Prosperity7's investment all the more significant.